Validity, reliability and responsiveness of Lupus Impact Tracker and LupusPRO: AURORA Trial (UKKW 2025) - Jun 9, 2025 - Abstract #461; "Voclosporin used in addition to mycophenolate mofetil and low dose oral steroids in patients with active lupus nephritis (LN) was found to be superior to placebo in Phase 3, global, double blind, randomized control trial (AURORA 1). both LIT and LupusPRO show good psychometric properties in this clinical trial, including responsiveness. LIT is short, while LupusPRO is comprehensive. For clinical trials, LIT or LupusPRO HRQOL domains inclusion may be more apt to capture proximal effects of the disease and the proposed intervention."
Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology
|
|
Dr Meenakshi Jolly1; Dr Matt Truman2; Dr Ronaldo Flato2; Dr Kathryn Dao2
|